APA (7th ed.) Citation

Hergenroeder, G., Faino, A., Bridges, G., Bartlett, L., McNamara, S., Strub, B., . . . Ramos, K. (2022). 195 Impact of elexacaftor/tezacaftor/ivacaftor on serum markers of fat-soluble vitamin levels in people with cystic fibrosis. Journal of Cystic Fibrosis, 21, S114. https://doi.org/10.1016/S1569-1993(22)00885-2

Chicago Style (17th ed.) Citation

Hergenroeder, G., A. Faino, G. Bridges, L. Bartlett, S. McNamara, B. Strub, D. Nichols, and K. Ramos. "195 Impact of Elexacaftor/tezacaftor/ivacaftor on Serum Markers of Fat-soluble Vitamin Levels in People with Cystic Fibrosis." Journal of Cystic Fibrosis 21 (2022): S114. https://doi.org/10.1016/S1569-1993(22)00885-2.

MLA (9th ed.) Citation

Hergenroeder, G., et al. "195 Impact of Elexacaftor/tezacaftor/ivacaftor on Serum Markers of Fat-soluble Vitamin Levels in People with Cystic Fibrosis." Journal of Cystic Fibrosis, vol. 21, 2022, p. S114, https://doi.org/10.1016/S1569-1993(22)00885-2.